357 related articles for article (PubMed ID: 19513105)
1. Regulatory T cell expansion in HTLV-1 and strongyloidiasis co-infection is associated with reduced IL-5 responses to Strongyloides stercoralis antigen.
Montes M; Sanchez C; Verdonck K; Lake JE; Gonzalez E; Lopez G; Terashima A; Nolan T; Lewis DE; Gotuzzo E; White AC
PLoS Negl Trop Dis; 2009 Jun; 3(6):e456. PubMed ID: 19513105
[TBL] [Abstract][Full Text] [Related]
2. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis.
Carvalho EM; Da Fonseca Porto A
Parasite Immunol; 2004; 26(11-12):487-97. PubMed ID: 15771684
[TBL] [Abstract][Full Text] [Related]
3. Involvement of IL-2/IL-2R system activation by parasite antigen in polyclonal expansion of CD4(+)25(+) HTLV-1-infected T-cells in human carriers of both HTLV-1 and S. stercoralis.
Satoh M; Toma H; Sugahara K; Etoh K; Shiroma Y; Kiyuna S; Takara M; Matsuoka M; Yamaguchi K; Nakada K; Fujita K; Kojima S; Hori E; Tanaka Y; Kamihira S; Sato Y; Watanabe T
Oncogene; 2002 Apr; 21(16):2466-75. PubMed ID: 11971181
[TBL] [Abstract][Full Text] [Related]
4. HTLV-1 decreases Th2 type of immune response in patients with strongyloidiasis.
Porto AF; Neva FA; Bittencourt H; Lisboa W; Thompson R; Alcântara L; Carvalho EM
Parasite Immunol; 2001 Sep; 23(9):503-7. PubMed ID: 11589779
[TBL] [Abstract][Full Text] [Related]
5. Interferon-gamma and interleukin-4 responses in relation to serum IgE levels in persons infected with human T lymphotropic virus type I and Strongyloides stercoralis.
Neva FA; Filho JO; Gam AA; Thompson R; Freitas V; Melo A; Carvalho EM
J Infect Dis; 1998 Dec; 178(6):1856-9. PubMed ID: 9815251
[TBL] [Abstract][Full Text] [Related]
6. [Combined infection with HTLV-1 and Strongyloides stercoralis].
Pays JF
Bull Soc Pathol Exot; 2011 Aug; 104(3):188-99. PubMed ID: 21800110
[TBL] [Abstract][Full Text] [Related]
7. Regulatory T cells and IgE expression in duodenal mucosa of Strongyloides stercoralis and human T lymphotropic virus type 1 co-infected patients.
Malpica L; White AC; Leguia C; Freundt N; Barros N; Chian C; Antunez EA; Montes M
PLoS Negl Trop Dis; 2019 Jun; 13(6):e0007415. PubMed ID: 31170141
[TBL] [Abstract][Full Text] [Related]
8. Strongyloides stercoralis and HTLV-1 coinfection in CD34+ cord blood stem cell humanized mice: Alteration of cytokine responses and enhancement of larval growth.
Springer LE; Patton JB; Zhan T; Rabson AB; Lin HC; Manser T; Lok JB; Hess JA; Abraham D
PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009559. PubMed ID: 34314415
[TBL] [Abstract][Full Text] [Related]
9. Normal serum IgE levels and eosinophil counts exhibited during Strongyloides stercoralis infection.
Higashiarakawa M; Hirata T; Tanaka T; Parrott G; Kinjo T; Naka H; Hokama A; Fujita J
Parasitol Int; 2017 Feb; 66(1):807-812. PubMed ID: 27744050
[TBL] [Abstract][Full Text] [Related]
10. Treatment of strongyloidiasis in HTLV-1 and Strongyloides stercoralis coinfected patients is associated with increased TNFα and decreased soluble IL2 receptor levels.
Salles F; Bacellar A; Amorim M; Orge G; Sundberg M; Lima M; Santos S; Porto A; Carvalho E
Trans R Soc Trop Med Hyg; 2013 Aug; 107(8):526-9. PubMed ID: 23843560
[TBL] [Abstract][Full Text] [Related]
11. Modulation of CD4
Anuradha R; Munisankar S; Bhootra Y; Dolla C; Kumaran P; Nutman TB; Babu S
Infect Immun; 2017 Nov; 85(11):. PubMed ID: 28874444
[No Abstract] [Full Text] [Related]
12. Reduced efficacy of treatment of strongyloidiasis in HTLV-I carriers related to enhanced expression of IFN-gamma and TGF-beta1.
Satoh M; Toma H; Sato Y; Takara M; Shiroma Y; Kiyuna S; Hirayama K
Clin Exp Immunol; 2002 Feb; 127(2):354-9. PubMed ID: 11876761
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory effects of concurrent HTLV-I infection in strongyloidiasis.
Atkins NS; Lindo JF; Lee MG; Hanchard B; Robinson RD; Bundy DA
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jun; 18(2):188-90. PubMed ID: 9637586
[No Abstract] [Full Text] [Related]
14. Regulatory T cell expansion resolves after effective strongyloidiasis treatment in subjects with HTLV-1 co-infection.
Hoces D; Barros N; Woll F; Bauer A; White AC; Montes M
Parasitol Int; 2020 Jun; 76():102092. PubMed ID: 32120049
[TBL] [Abstract][Full Text] [Related]
15. Correlation between human T cell lymphotropic virus type-1 and Strongyloides stercoralis infections and serum immunoglobulin E responses in residents of Okinawa, Japan.
Hayashi J; Kishihara Y; Yoshimura E; Furusyo N; Yamaji K; Kawakami Y; Murakami H; Kashiwagi S
Am J Trop Med Hyg; 1997 Jan; 56(1):71-5. PubMed ID: 9063365
[TBL] [Abstract][Full Text] [Related]
16. Case Report:
De Souza JN; Soares BNRR; Goes LL; Lima CS; Barreto NMPV; Jacobina BS; Gonçalves N; Teixeira MCA; Galvão-Castro B; Grassi MFR; Soares NM
Am J Trop Med Hyg; 2018 Dec; 99(6):1583-1586. PubMed ID: 30277207
[No Abstract] [Full Text] [Related]
17. [Clinical and immunological consequences of the association between HTLV-1 and strongyloidiasis].
Porto MA; Muniz A; Oliveira Júnior J; Carvalho EM
Rev Soc Bras Med Trop; 2002; 35(6):641-9. PubMed ID: 12612748
[TBL] [Abstract][Full Text] [Related]
18. Parasite Antigen-Specific Regulation of Th1, Th2, and Th17 Responses in Strongyloides stercoralis Infection.
Anuradha R; Munisankar S; Dolla C; Kumaran P; Nutman TB; Babu S
J Immunol; 2015 Sep; 195(5):2241-50. PubMed ID: 26202988
[TBL] [Abstract][Full Text] [Related]
19. Strongyloides stercoralis hyperinfection in a carrier of HTLV-I virus with evidence of selective immunosuppression.
Newton RC; Limpuangthip P; Greenberg S; Gam A; Neva FA
Am J Med; 1992 Feb; 92(2):202-8. PubMed ID: 1543206
[TBL] [Abstract][Full Text] [Related]
20. Strongyloidiasis and infective dermatitis alter human T lymphotropic virus-1 clonality in vivo.
Gillet NA; Cook L; Laydon DJ; Hlela C; Verdonck K; Alvarez C; Gotuzzo E; Clark D; Farré L; Bittencourt A; Asquith B; Taylor GP; Bangham CR
PLoS Pathog; 2013; 9(4):e1003263. PubMed ID: 23592987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]